LeonaBio (LONA) Other financing activities (2020 - 2023)
LeonaBio (LONA) posted quarterly Other financing activities of $99000.0 for Q1 2023, down 52.86% year-over-year from $210000.0 in Q1 2022, and down 52.86% quarter-over-quarter from $210000.0 in Q1 2022.
LeonaBio (LONA) Other financing activities (2020 - 2023) Analysis & Trends
LeonaBio (LONA) has reported Other financing activities for 4 consecutive years, with $99000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Other financing activities fell 52.86% year-over-year to $99000.0; the TTM figure through Mar 2023 stood at $309000.0 (up 254.5% YoY), while the FY2021 annual figure was $96.8 million, down 53.6% from the prior year.
- Other financing activities declined to $99000.0 in Q1 2023 per LONA's latest filing, from $210000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $97.2 million in Q1 2021 and bottomed at -$410000.0 in Q2 2021.
- Historically, Other financing activities has averaged $23.7 million across 4 years, with a median of $210000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other financing activities slumped 99.78% — and 2023, when it plunged 52.86%.
- LeonaBio's Other financing activities stood at $21.3 million in 2020, then slumped by 101.93% to -$410000.0 in 2021, then soared by 151.22% to $210000.0 in 2022, then slumped by 52.86% to $99000.0 in 2023.
- Business Quant data shows LONA's Other financing activities at $99000.0 in Q1 2023, $210000.0 in Q1 2022, and -$410000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 99,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Jun 30, 2021 | -410,000.00 |
| Jun 30, 2021 | -410,000.00 |
| Mar 31, 2021 | 97.17 Mn |
| Mar 31, 2021 | 97.17 Mn |
| Dec 31, 2020 | 21.29 Mn |
| Dec 31, 2020 | 21.29 Mn |